All three doses of orforglipron (6 mg, 12 mg, and 36 mg) met the primary and all key secondary endpoints by showing significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors compared with placebo at 72 weeks
The Journal of endocrinology , 165 (3), 569577
Because our carb and fat intake has increased so much relative to carbohydrates, our overall percentage of total calories from protein (i.e., protein %) has decreased
As the landscape of longevity medicine shifts in 2026, many individuals are moving away from unregulated research chemicals toward medically supervised peptide protocols designed to optimize sleep, body composition, and recovery
By mimicking the effects of GLP-1, semaglutide helps to lower blood sugar levels in individuals with type 2 diabetes
The benefits of vitamin shots may vary depending on the specific vitamins and minerals being administered